AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
58 hedge funds and large institutions have $16.5M invested in Asterias Biotherapeutics Inc. Series A in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $121K
Holders
58
Holding in Top 10
1
Calls
–
Puts
$121K
Top Buyers
| 1 | +$421K | |
| 2 | +$391K | |
| 3 | +$288K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$236K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$194K |
Top Sellers
| 1 | -$753K | |
| 2 | -$617K | |
| 3 | -$106K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$97K |
| 5 |
Citigroup
New York
|
-$96.9K |